NEBOKITUG
UNII 7SGW2C2ZH7

Substance Identification & Data

This profile provides standardized clinical and technical data for Nebokitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7SGW2C2ZH7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2922315-59-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7SGW2C2ZH7

CAS Registry Number

2922315-59-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NEBOKITUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C211745

National Cancer Institute reference terminology for clinical and research data.

INN ID

13178

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-173

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nebokitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NEBOKITUG

Common Names & Synonyms

CM-101 CCL24 BLOCKING MONOCLONAL ANTIBODY

H-GAMMA1 HEAVY CHAIN (1-450) (VH MUSMUS/HOMSAP (MUS MUSCULUS IGHV9-3-1*01 (90.7%) -(IGHD) -IGHJ4*01 (93.8%)/HOMO SAPIENS IGHV7-4-1*02 (73.2%) -(IGHD) -IGHJ5*01 (84.6%) L123>S (115), CDRIMGT (8.8.13) (26-33.51-58.97-109)) (1-120) -HOMO SAPIENS IGHG1*03 (100%) G1M3, NG1M1 CH1 R120, CH3 E12, M14 (CH1 R120 (217) (121-218), HINGE 1-15 (219-233), CH2 (234-343), CH3 E12 (359), M14 (361) (344-448), CHS (449-450)) (121-450)), (223-218')-DISULFIDE WITH L-KAPPA LIGHT CHAIN (1'-218') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV3-4*01 (86.9%) -IGKJ1*01 (91.7%) L124>V (108)/HOMO SAPIENS IGKV4-1*01 (76.2%) -IGKJ4*01 (100%), CDR-IMGT (10.3.9) (27'-36'.54'-56'.93'-101')) (1'-111') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (CKAPPA A45.1 (157'), V101 (195')) (112'-218')); DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA

IMMUNOGLOBULIN G1, ANTI-(HUMAN EOTAXIN 2) (HUMAN-MUS MUSCULUS MONOCLONAL CM101 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CM-101 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CCL24 (C-C MOTIF CHEMOKINE LIGAND 24, SCYA24, SMALL INDUCIBLE CYTOKINE SUBFAMILY A (CYS-CYS) MEMBER 24, MPIF-2, MYELOID PROGENITOR INHIBITORY FACTOR 2, EOTAXIN-2))

NEBOKITUG [INN]

NEBOKITUG [USAN]